These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 39260850)
1. Incidence, symptom clusters and determinants of post-acute COVID symptoms: a population-based surveillance in community-dwelling users of the COVID RADAR app. van Dijk WJ; Haaksma ML; Mook-Kanamori DO; Visser LG; Numans ME; van Hylckama Vlieg A; Rosendaal FR; Kiefte-de Jong JC BMJ Open; 2024 Sep; 14(9):e087235. PubMed ID: 39260850 [TBL] [Abstract][Full Text] [Related]
2. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857 [TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099 [TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140 [TBL] [Abstract][Full Text] [Related]
5. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study. Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159 [TBL] [Abstract][Full Text] [Related]
8. COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19. van Dijk WJ; Saadah NH; Numans ME; Aardoom JJ; Bonten TN; Brandjes M; Brust M; le Cessie S; Chavannes NH; Middelburg RA; Rosendaal F; Visser LG; Kiefte-de Jong J PLoS One; 2021; 16(6):e0253566. PubMed ID: 34191828 [TBL] [Abstract][Full Text] [Related]
9. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Canas LS; Molteni E; Deng J; Sudre CH; Murray B; Kerfoot E; Antonelli M; Rjoob K; Capdevila Pujol J; Polidori L; May A; Österdahl MF; Whiston R; Cheetham NJ; Bowyer V; Spector TD; Hammers A; Duncan EL; Ourselin S; Steves CJ; Modat M Lancet Digit Health; 2023 Jul; 5(7):e421-e434. PubMed ID: 37202336 [TBL] [Abstract][Full Text] [Related]
10. Symptoms before and after COVID-19: a population and case-control study using prospective data. Sudre CH; Antonelli M; Cheetham NJ; Molteni E; Canas LS; Bowyer V; Murray B; Rjoob K; Modat M; Capdevila Pujol J; Hu C; Wolf J; Spector TD; Hammers A; Steves CJ; Ourselin S; Duncan EL Eur Respir J; 2024 Jul; 64(1):. PubMed ID: 38575161 [TBL] [Abstract][Full Text] [Related]
11. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study. Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021. Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626 [TBL] [Abstract][Full Text] [Related]
13. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection. Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH; JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247 [TBL] [Abstract][Full Text] [Related]
14. Associations Between Acute COVID-19 Symptom Profiles and Long COVID Prevalence: Population-Based Cross-Sectional Study. Hirschtick JL; Slocum E; Xie Y; Power LE; Elliott MR; Orellana RC; Fleischer NL JMIR Public Health Surveill; 2024 Oct; 10():e55697. PubMed ID: 39352725 [TBL] [Abstract][Full Text] [Related]
15. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735 [TBL] [Abstract][Full Text] [Related]
16. Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20-21 Registry. Arango-Ibanez JP; Córdoba-Melo BD; Gutiérrez Posso JM; Barbosa-Rengifo MM; Herrera CJ; Quintana Da Silva MA; Buitrago AF; Coronel Gilio ML; Pow-Chong-Long F; Gómez-Mesa JE Viruses; 2024 Jun; 16(7):. PubMed ID: 39066191 [TBL] [Abstract][Full Text] [Related]
17. Post-acute sequelae of covid-19 six to 12 months after infection: population based study. Peter RS; Nieters A; Kräusslich HG; Brockmann SO; Göpel S; Kindle G; Merle U; Steinacker JM; Rothenbacher D; Kern WV; BMJ; 2022 Oct; 379():e071050. PubMed ID: 36229057 [TBL] [Abstract][Full Text] [Related]
18. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Caspersen IH; Magnus P; Trogstad L Eur J Epidemiol; 2022 May; 37(5):539-548. PubMed ID: 35211871 [TBL] [Abstract][Full Text] [Related]
19. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study. Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035 [TBL] [Abstract][Full Text] [Related]
20. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A; Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]